Skip to main content

Table 1 Comparison of clinical characteristics and endocrine parameters in PCOS and non-PCOS patients for mRNA analysis

From: Hsa_circ_0043532 contributes to PCOS through upregulation of CYP19A1 by acting as a ceRNA for hsa-miR-1270

Basic parameters

PCOS (n = 31)

non-PCOS (n = 47)

p-values

Age (years)

30.0 ± 3.0

30.3 ± 2.5

NS

Infertility duration(yr)

2.7 ± 1.3

3.0 ± 1.8

NS

BMI (kg/m2)

24.8 ± 3.9

22.5 ± 3.2

 < 0.001

FSH (mIU/ml)

7.88 ± 2.86

8.71 ± 2.95

NS

LH (mIU/ml)

6.68 ± 5.60

4.73 ± 2.72

NS

LH/FSH

1.07 ± 1.12

0.64 ± 0.42

NS

PRL (ng/ml)

18.03 ± 10.93

20.50 ± 9.36

NS

P (ng/ml)

0.43 ± 0.39

0.45 ± 0.35

NS

AMH (ng/ml)

6.39 ± 3.51

3.56 ± 1.98

 < 0.0001

E2 (pg/ml)

39.79 ± 7.48

33.50 ± 11.68

NS

T (ng/ml)

1.22 ± 0.38

0.73 ± 0.36

 < 0.0001

FBG (mmol/L)

5.01 ± 0.46

4.94 ± 0.40

NS

Antral follicle count

31.10 ± 12.66

16.36 ± 6.62

 < 0.0001

oocytes obtained

17.59 ± 6.19

14.66 ± 7.12

 < 0.05

Embryo ratea

0.39 ± 0.19

0.43 ± 0.14

NS

  1. Data are presented as the mean ± SD, p < 0.05 is considered to be statistically significant
  2. BMI body mass inde, FSH follicle-stimulating hormone, LH luteinizing hormone, PRL prolactin, P Progesterone, AMH anti-Müllerian hormone, E2 estradiol, T testosterone, FBG Fasting blood glucose
  3. aEmbryo rate = number of embryos/oocytes obtained